Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Orphanet Journal of Rare Diseases
|
March 28, 2013
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Deniz Güngör, Michelle E Kruijshaar, Iris Plug, et al.
Developmental Medicine and Child Neurology
|
May 26, 2017
Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype
Audrey A M Vollebregt, Marianne Hoogeveen-Westerveld, Marian A Kroos, et al.
Journal of Inherited Metabolic Disease
|
November 5, 2015
Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up
Deniz Güngör, Michelle E Kruijshaar, Iris Plug, et al.
Blood
|
August 17, 2004
Thirty years of hemophilia treatment in the Netherlands, 1972-2001
Iris Plug, Johanna G van der Bom, Marjolein Peters, et al.
Blood
|
March 23, 2006
Bleeding in carriers of hemophilia
Iris Plug, Eveline P Mauser-Bunschoten, Annette H J T Bröcker-Vriends, et al.
Orphanet Journal of Rare Diseases
|
April 6, 2013
Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
Marion M Brands, Marianne Hoogeveen-Westerveld, Marian A Kroos, et al.
Molecular Genetics and Metabolism
|
May 30, 2017
A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI
Esmee Oussoren, Johannes H J M Bessems, Virginie Pollet, et al.
Developmental Medicine and Child Neurology
|
March 25, 2018
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain
Berendine J Ebbink, Esther Poelman, Femke K Aarsen, et al.
Molecular Genetics and Metabolism
|
March 26, 2013
Up to five years experience with 11 mucopolysaccharidosis type VI patients
Marion M M G Brands, Esmee Oussoren, George J G Ruijter, et al.
BMC Public Health
|
May 15, 2012
Socioeconomic inequalities in mortality from conditions amenable to medical interventions: do they reflect inequalities in access or quality of health care?
Iris Plug, Rasmus Hoffmann, Barbara Artnik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Orphanet Journal of Rare Diseases
|
March 28, 2013
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Deniz Güngör, Michelle E Kruijshaar, Iris Plug, et al.
Developmental Medicine and Child Neurology
|
May 26, 2017
Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype
Audrey A M Vollebregt, Marianne Hoogeveen-Westerveld, Marian A Kroos, et al.
Journal of Inherited Metabolic Disease
|
November 5, 2015
Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up
Deniz Güngör, Michelle E Kruijshaar, Iris Plug, et al.
Blood
|
August 17, 2004
Thirty years of hemophilia treatment in the Netherlands, 1972-2001
Iris Plug, Johanna G van der Bom, Marjolein Peters, et al.
Blood
|
March 23, 2006
Bleeding in carriers of hemophilia
Iris Plug, Eveline P Mauser-Bunschoten, Annette H J T Bröcker-Vriends, et al.
Orphanet Journal of Rare Diseases
|
April 6, 2013
Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
Marion M Brands, Marianne Hoogeveen-Westerveld, Marian A Kroos, et al.
Molecular Genetics and Metabolism
|
May 30, 2017
A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI
Esmee Oussoren, Johannes H J M Bessems, Virginie Pollet, et al.
Developmental Medicine and Child Neurology
|
March 25, 2018
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain
Berendine J Ebbink, Esther Poelman, Femke K Aarsen, et al.
Molecular Genetics and Metabolism
|
March 26, 2013
Up to five years experience with 11 mucopolysaccharidosis type VI patients
Marion M M G Brands, Esmee Oussoren, George J G Ruijter, et al.
BMC Public Health
|
May 15, 2012
Socioeconomic inequalities in mortality from conditions amenable to medical interventions: do they reflect inequalities in access or quality of health care?
Iris Plug, Rasmus Hoffmann, Barbara Artnik, et al.
Page
of 3